Efficacy of Orlistat 60 mg on Weight Loss and Body Fat Mass in US Army Soldiers

Journal of the Academy of Nutrition and Dietetics

Volumn 112, Issue 4, 2012, Pages 533-540

  Smith, Tracey J ^a   Crombie, Aaron ^a   Sanders, LesLee Funderburk ^a,b   Sigrist, Lori D ^a,c   Bathalon, Gaston P ^a   McGraw, Susan ^a   Young, Andrew J ^a  

^a U S ARMY RESEARCH INSTITUTE OF ENVIRONMENTAL MEDICINE   (United States)

^b WILLIAM BEAUMONT ARMY MEDICAL CENTER   (United States)

^c Graduate Program in Nutrition   (United States)

Author keywords

Body fat loss; Military; Pharmacotherapy; Weight loss

Indexed keywords

ANTIOBESITY AGENT; LACTONE; TETRAHYDROLIPSTATIN;

ADIPOSE TISSUE; ANTHROPOMETRY; ARTICLE; BODY COMPOSITION; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; EXERCISE; FEMALE; HEALTH EDUCATION; HUMAN; LOW CALORY DIET; LOW FAT DIET; MALE; METABOLISM; OBESITY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; WEIGHT REDUCTION;

ADIPOSE TISSUE; ANTHROPOMETRY; ANTI-OBESITY AGENTS; BODY COMPOSITION; BODY MASS INDEX; DIET, FAT-RESTRICTED; DIET, REDUCING; EXERCISE; FEMALE; HEALTH EDUCATION; HUMANS; LACTONES; MALE; OBESITY; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 84859107260     PISSN: 22122672     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jada.2011.10.006     Document Type: Article

References (24)

1. Bray R.M., Pemberton M.R., Hourani L.L., et al. 2008 Department of Defense Survey of Health Related Behaviors Among Active Duty Military Personnel 2009, RTI International, Research Triangle Park, NC.
2. Mokdad A.H. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003, 289(1):76-79.
3. Finkelstein E.A., Chen H., Prabhu M., Trogdon J.G., Corso P.S. The relationship between obesity and injuries among U.S. adults. Am J Health Promot 2007, 21(5):460-468.
4. Mattila V.M., Niva M., Kiuru M., Pihlajamaki H. Risk factors for bone stress injuries: A follow-up study of 102,515 person-years. Med Sci Sports Exerc 2007, 39(7):1061-1066.
5. Dall T.M., Zhang Y., Chen Y.J., et al. Cost associated with being overweight and with obesity, high alcohol consumption, and tobacco use within the military health system's TRICARE prime-enrolled population. Am J Health Promot 2007, 22(2):120-139.
6. AR 600-9, The Army Weight Control Program 2006, US Department of the Army, Department of the Army, Washington, DC.
7. FDA approves orlistat for over-the-counter use Food and Drug Administration Web site, Published February 7, 2007. Updated June 18, 2009.Accessed December 5, 2008. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2007/ucm108839.htm.
8. Anderson J.W., Schwartz S.M., Hauptman J., et al. Low-dose orlistat effects on body weight of mildly to moderately overweight individuals: A 16 week, double-blind, placebo-controlled trial. Ann Pharmacother 2006, 40(10):1717-1723.
9. Hauptman J., Lucas C., Boldrin M.N., Collins H., Segal K.R. Orlistat in the long-term treatment of obesity in primary care settings. Arch Fam Med 2000, 9(2):160-167.
10. Rossner S., Sjostrom L., Noack R., Meinders A.E., Noseda G. Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity. Obes Res 2000, 8(1):49-61.
11. Van Gaal L.F., Broom J.I., Enzi G., Toplak H. Efficacy and tolerability of orlistat in the treatment of obesity: A 6-month dose-ranging study. Eur J Clin Pharmacol 1998, 54(2):125-132.
12. ALLI (orlistat) capsule label National Institutes of Health Web site, Published February 7, 2007. Updated May 1, 2011.Accessed December 14, 2010. http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a2d3bd73-f3af-4ea5-a57c-66b0004cfe4f.
13. Cobas 6000 Analyzer Series 2005, [operator's manual], Roche Diagnostics, Mannheim, Germany.
14. Warnick G.R., Knopp R.H., Fitzpatrick V., Branson L. Estimating low-density lipoprotein cholesterol by the Friedewald equation is adequate for classifying patients on the basis of nationally recommended cutpoints. Clin Chem 1990, 36(1):15-19.
15. Chobanian A.V., Bakris G.L., Black H.R., et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 2003, 289(19):2560-2572.
16. Ahrens R.A., Hower M., Best A.M. Effects of weight reduction interventions by community pharmacists. J Am Pharm Assoc 2003, 43(5):583-589.
17. Ashley J.M., St Jeor S.T., Perumean-Chaney S., Schrage J., Bovee V. Meal replacements in weight intervention. Obes Res 2001, 9(suppl 4):312S-320S.
18. Ditschuneit H.H., Flechtner-Mors M. Value of structured meals for weight management: Risk factors and long-term weight maintenance. Obes Res 2001, 9(suppl 4):284S-289S.
19. Hensrud D.D. Dietary treatment and long-term weight loss and maintenance in type 2 diabetes. Obes Res 2001, 9(suppl 4):348S-353S.
20. Noakes M., Foster P.R., Keogh J.B., Clifton P.M. Meal replacements are as effective as structured weight-loss diets for treating obesity in adults with features of metabolic syndrome. J Nutr 2004, 134(8):1894-1899.
21. Rothacker D.Q., Staniszewski B.A., Ellis P.K. Liquid meal replacement vs traditional food: A potential model for women who cannot maintain eating habit change. J Am Diet Assoc 2001, 101(3):345-347.
22. Smith T.J., Sigrist L.D., Bathalon G.P., McGraw S., Karl J.P., Young A.J. Efficacy of a meal-replacement program for promoting blood lipid changes and weight and body fat loss in US Army soldiers. J Am Diet Assoc 2010, 110(2):268-273.
23. Hodgdon J.A., Fried K.E. Development of the DoD Body Composition Estimation Equation 1999, US Naval Health Research Center, San Diego, CA.
24. Lohman T.G. Dual energy x-ray absorptiometry. Human Body Composition 2005, 63-78. Human Kinetics, Champaign, IL. 1st ed. A.F. Roche, S.B. Heymsfield, T.G. Lohman (Eds.).